Related Experiment Video
Updated: Apr 30, 2026

Measurements of Physiological Stress Responses in C. Elegans
Published on: May 21, 2020
The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response
M Hussong1, S T Börno2, M Kerick2
11] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany [2] Department of Biology, Chemistry and Pharmacy, Free University, Berlin, Germany.
Abstract:
The epigenetic sensor BRD4 (bromodomain protein 4) is a potent target for anti-cancer therapies. To study the transcriptional impact of BRD4 in cancer, we generated an expression signature of BRD4 knockdown cells and found oxidative stress response genes significantly enriched. We integrated the RNA-Seq results with DNA-binding sites of BRD4 generated by chromatin immunoprecipitations, correlated these with gene expressions from human prostate cancers and identified 21 top BRD4 candidate genes among which the oxidative stress pathway genes KEAP1, SESN3 and HDAC6 are represented. Knock down of BRD4 or treatment with the BRD4 inhibitor JQ1 resulted in decreased reactive oxygen species (ROS) production and increased cell viability under H2O2 exposure. Consistently, a deregulation of BRD4 diminished the KEAP1/NRF2 axis and led to a disturbed regulation of the inducible heme oxygenase 1 (HMOX1). Without exogenous stress induction, we also found BRD4 directly targeting the HMOX1 promoter over the SP1-binding sites. Our findings provide insight into the transcriptional regulatory network of BRD4 and highlight BRD4 as signal transducer of the cellular response to oxidative stress.
Insights
Bromodomain protein 4 (BRD4) regulates oxidative stress response genes in cancer. Inhibiting BRD4 reduces reactive oxygen species (ROS) and enhances cell survival, revealing BRD4
Area of Science:
- Cancer Biology
- Epigenetics
- Molecular Oncology
Background:
- Bromodomain protein 4 (BRD4) is an epigenetic regulator and a promising anti-cancer target.
- BRD4's role in regulating transcriptional networks, particularly in cancer, requires further elucidation.
- Understanding BRD4's impact on cellular stress responses is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the transcriptional effects of BRD4 in cancer.
- To identify key BRD4-regulated genes involved in oxidative stress pathways.
- To explore the functional consequences of BRD4 modulation on cancer cell response to oxidative stress.
Main Methods:
- Generation of BRD4 knockdown cell expression signatures using RNA-Sequencing.
- Integration of RNA-Seq data with BRD4 chromatin immunoprecipitation (ChIP) sequencing data.
- Correlation analysis of BRD4 target genes with gene expression data from human prostate cancers.
- Assessment of reactive oxygen species (ROS) production and cell viability under hydrogen peroxide (H2O2) exposure following BRD4 knockdown or inhibition.
- Analysis of the KEAP1/NRF2 axis and heme oxygenase 1 (HMOX1) regulation.
Main Results:
- BRD4 knockdown enriched for oxidative stress response genes, including KEAP1, SESN3, and HDAC6.
- BRD4 inhibition (using JQ1) or knockdown decreased ROS production and increased cell viability under H2O2 exposure.
- BRD4 deregulation disrupted the KEAP1/NRF2 axis and impaired the regulation of HMOX1.
- BRD4 was found to directly target the HMOX1 promoter, independent of exogenous stress induction.
Conclusions:
- BRD4 acts as a key transcriptional regulator of oxidative stress response genes in cancer.
- Targeting BRD4 modulates cellular redox balance and impacts cancer cell survival under stress.
- BRD4 is identified as a critical signal transducer in the cellular response to oxidative stress, offering therapeutic potential.
Related Concept Videos
Regulation of the Unfolded Protein Response
Other Stress Responses in Bacteria
Cell Signaling in Plants
The Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of Nuclear Protein Sorting
